Pharmaceuticals

Global Antiepileptic Drugs Market (Drug Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

  • ALL22983
  • 0 Pages
  • November 1999
  • Pharmaceuticals

Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures. The epileptic seizures show recurring episodes and occur due to wrong signal sent by nerve cells to the brain. Antiepileptic drugs also act as mood stabilizers and also used in the treatment of bipolar disorders or neuropathic pain. Antiepileptics market is specifically driven due to new drug approvals over the past few years. However, recent patent expiration of major brand such as Lamictal is expected to hinder the growth of the market. GlaxoSmithKline, Johnson & Johnson, Sanofi, Pfizer, Novartis, Abbott, Sunovion Pharmaceuticals, and Cephalon are some of the key leaders of global antiepileptic drugs market. Generic competition has dramatically increased for antiepileptics due to patent expiration of major brands and in future, it would be responsible for down pricing of branded drugs. Lyrica was the largest selling antiepileptic brand owing to its highly efficacious nature. Retigabine and perampanel are recently approved antiepileptics, which act through new molecular targets.

Antiepileptic drugs market is segmented based on drug type and geography. Drug type segment is further categorized into two broad categories, namely first and second-generation antiepileptic drugs. Phenytoin, carbamazepine, oxycarbazepine and valproate from the first generation class, dominates the overall antiepileptics market. From the second-generation drugs, zonisamide, levetiracetam, and lacosamide are gaining popularity due to their tolerability and high efficacy. Geographically, global antiepileptic drugs market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America and Europe dominates the global market due to extensive R&D efforts and presence of approved second-generation antiepileptics. Asia-pacific is the fastest growing market owing to widespread prevalence of epilepsy and better penetration of antiepileptic drugs. In-depth coverage of the global antiepileptic drugs market including drivers, restraints and opportunities would help professionals to better understand market behavior. Porter’s Five Forces analysis examines the competitive structure of the global antiepileptic drugs market and it would assist market strategists in their respective decision making process. Pinpointed analysis of geographic segments would help to identify opportunities for growth within the global antiepileptic drugs market.

KEY BENEFITS

  • This report offers the following benefits in particular:
  • In-depth coverage of the global antiepileptic drugs market including drivers, restraints and opportunities would help professionals to better understand market behavior 
  • Porter’s Five Forces analysis examines the competitive structure of the global antiepileptic drugs market and it would assist market strategists in their respective decision making process 
  • Pinpointed analysis of geographic segments helps to identify opportunities for growth within the global antiepileptic drugs market
  • Detailed study of the strategies of key leaders, partnerships and acquisitions in the global antiepileptic drugs market would be informative for professionals in the corporate sector 

KEY MARKET SEGMENTS

The global antiepileptic drugs market is segmented into two major categories such as drug type and geography. 

MARKET BY DRUG TYPE

  • First Generation AEDs
    • Phenytoin (Dilantin, Phenytek)
    • Carbamazepine (Carbatrol) 
    • Oxycarbazepine (Trileptal)
    • Valproate (Depakote)
    • Topiramate (Topamax)
    • Ethosuximide (Zarontin) 
    • Primidone (Mysoline)
    • Phenobarbital (Luminal)
  • Second Generation AEDs
    • Lamotrigine (Lamictal) 
    • Pregabalin (Lyrica)
    • Rufinamide (Banzel/Inovelon)
    • Levetiracetam (Keppra) 
    • Ezogabine/retigabine (Trobalt/Potiga) 
    • Lacosamide (Vimpat) 
    • Eslicarbazepine acetate (Aptiom) 
    • Zonisamide (Zonegran) 
    • Perampanel (Fycompa) 

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Pharmaceutical Excipients Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Over the Counter (OTC) & Diet Supplementary Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>